Vertex Pharmaceuticals Q4 2023 Financial Results

Vertex Pharmaceuticals presented fourth quarter and full year 2023 financial results on February 5, 2024, outlining commercial updates and pipeline progress across cystic fibrosis, acute pain, and blood disorders. The presentation includes CEO perspective on development timelines, commercial strategies for CASGEVY and other lead programs, and financial performance metrics for the year.